| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.731 | 0.005 | 0.812 | Anticonvulsant | 0.225 0.067 DBMET00282 0.533 0.01 DBMET01092 0.812 0.004 DBMET01093 0.222 0.069 DBMET01097 | DBMET01093 | |
| 0.573 | 0.009 | 0.573 | Cardiotonic | 0.436 0.023 DBMET00282 0.47 0.018 DBMET01092 0.277 0.067 DBMET01097 | ||
| 0.51 | 0.022 | 0.551 | Spasmolytic | 0.342 0.055 DBMET00282 0.551 0.018 DBMET01092 0.42 0.036 DBMET01093 0.394 0.041 DBMET01097 | DBMET01092 | |
| 0.458 | 0.011 | 0.533 | Anesthetic general | 0.27 0.042 DBMET00282 0.482 0.009 DBMET01092 0.533 0.006 DBMET01093 0.169 0.095 DBMET01094 0.17 0.094 DBMET01095 0.247 0.052 DBMET01096 0.367 0.021 DBMET01097 | DBMET01093 | |
| 0.363 | 0.029 | 0.363 | Psychostimulant | 0.341 0.033 DBMET01092 0.322 0.037 DBMET01093 0.188 0.087 DBMET01095 0.303 0.042 DBMET01096 0.232 0.065 DBMET01097 0.15 0.116 DBMET01098 | ||
| 0.327 | 0.01 | 0.327 | Acetylcholine M1 receptor antagonist | 0.201 0.042 DBMET00282 0.322 0.011 DBMET01092 0.179 0.053 DBMET01093 0.131 0.094 DBMET01097 | ||
| 0.284 | 0.007 | 0.284 | GABA receptor agonist | 0.099 0.078 DBMET00282 0.225 0.013 DBMET01092 0.172 0.026 DBMET01093 | ||
| 0.334 | 0.062 | 0.334 | Calcium channel activator | 0.249 0.148 DBMET00282 0.318 0.075 DBMET01092 0.247 0.15 DBMET01093 0.303 0.088 DBMET01095 0.277 0.116 DBMET01096 0.334 0.061 DBMET01097 0.266 0.129 DBMET01098 | ||
| 0.372 | 0.101 | 0.45 | Calcium channel L-type activator | 0.235 0.222 DBMET00282 0.45 0.05 DBMET01092 0.406 0.077 DBMET01093 0.275 0.18 DBMET01097 0.275 0.18 DBMET01098 | DBMET01092 | |
| 0.304 | 0.042 | 0.353 | DNA synthesis inhibitor | 0.215 0.102 DBMET00282 0.335 0.034 DBMET01092 0.353 0.03 DBMET01093 0.242 0.072 DBMET01094 0.291 0.047 DBMET01095 0.303 0.042 DBMET01096 0.22 0.094 DBMET01097 0.234 0.079 DBMET01098 | DBMET01093 | |
| 0.268 | 0.012 | 0.268 | Acetylcholine muscarinic antagonist | 0.153 0.042 DBMET00282 0.263 0.013 DBMET01092 0.151 0.043 DBMET01093 0.102 0.088 DBMET01097 | ||
| 0.283 | 0.036 | 0.316 | RNA-directed DNA polymerase inhibitor | 0.167 0.158 DBMET00282 0.312 0.029 DBMET01092 0.316 0.029 DBMET01093 0.195 0.108 DBMET01095 0.196 0.105 DBMET01096 0.225 0.069 DBMET01098 | DBMET01093 | |
| 0.256 | 0.012 | 0.262 | ATPase inhibitor | 0.216 0.026 DBMET00282 0.262 0.011 DBMET01092 0.249 0.014 DBMET01093 0.187 0.049 DBMET01094 0.169 0.072 DBMET01095 0.211 0.029 DBMET01097 | DBMET01092 | |
| 0.283 | 0.042 | 0.35 | Tyrosine 3 hydroxylase inhibitor | 0.229 0.092 DBMET00282 0.35 0.016 DBMET01092 0.309 0.029 DBMET01093 0.199 0.138 DBMET01094 0.27 0.051 DBMET01095 0.236 0.082 DBMET01096 0.281 0.043 DBMET01097 0.247 0.071 DBMET01098 | DBMET01092 | |
| 0.335 | 0.094 | 0.539 | GABA C receptor rho-3 antagonist | 0.208 0.198 DBMET00282 0.368 0.077 DBMET01092 0.284 0.127 DBMET01093 0.539 0.017 DBMET01095 0.309 0.11 DBMET01096 0.22 0.184 DBMET01097 0.352 0.085 DBMET01098 | DBMET01095 | |
| 0.291 | 0.054 | 0.46 | Superoxide dismutase inhibitor | 0.365 0.033 DBMET00282 0.363 0.034 DBMET01092 0.218 0.1 DBMET01093 0.455 0.018 DBMET01094 0.46 0.017 DBMET01095 0.392 0.028 DBMET01097 | DBMET01095 | |
| 0.256 | 0.02 | 0.256 | Cholinergic antagonist | 0.148 0.054 DBMET00282 0.241 0.023 DBMET01092 0.124 0.07 DBMET01093 | ||
| 0.244 | 0.021 | 0.244 | Acetylcholine antagonist | 0.135 0.059 DBMET00282 0.227 0.024 DBMET01092 0.116 0.074 DBMET01093 | ||
| 0.23 | 0.011 | 0.298 | Cyclooxygenase 3 inhibitor | 0.186 0.024 DBMET00282 0.256 0.008 DBMET01092 0.146 0.052 DBMET01093 0.143 0.054 DBMET01094 0.298 0.006 DBMET01097 | DBMET01097 | |
| 0.232 | 0.016 | 0.232 | Antineoplastic antibiotic | 0.227 0.017 DBMET01092 0.2 0.021 DBMET01093 0.07 0.065 DBMET01095 | ||
| 0.273 | 0.061 | 0.424 | 5 Hydroxytryptamine uptake stimulant | 0.188 0.177 DBMET00282 0.265 0.067 DBMET01092 0.271 0.063 DBMET01093 0.424 0.01 DBMET01095 0.219 0.119 DBMET01096 0.209 0.135 DBMET01097 0.23 0.103 DBMET01098 | DBMET01095 | |
| 0.278 | 0.067 | 0.289 | DNA damaging | 0.289 0.062 DBMET01092 0.219 0.101 DBMET01093 0.252 0.079 DBMET01096 0.159 0.158 DBMET01097 | DBMET01092 | |
| 0.235 | 0.024 | 0.235 | 5 Hydroxytryptamine 3E antagonist | 0.174 0.122 DBMET00282 0.188 0.087 DBMET01092 0.209 0.049 DBMET01093 0.165 0.153 DBMET01094 0.22 0.036 DBMET01095 0.18 0.105 DBMET01096 0.197 0.068 DBMET01098 | ||
| 0.335 | 0.129 | 0.426 | 5 Hydroxytryptamine release inhibitor | 0.418 0.067 DBMET00282 0.358 0.109 DBMET01092 0.371 0.098 DBMET01093 0.312 0.152 DBMET01094 0.303 0.161 DBMET01095 0.276 0.194 DBMET01096 0.426 0.063 DBMET01097 0.374 0.096 DBMET01098 | DBMET01097 | |
| 0.228 | 0.025 | 0.228 | Anesthetic local | 0.197 0.033 DBMET01092 0.15 0.049 DBMET01093 0.131 0.059 DBMET01095 | ||
| 0.296 | 0.093 | 0.379 | Cholesterol antagonist | 0.27 0.111 DBMET00282 0.355 0.062 DBMET01092 0.379 0.054 DBMET01093 0.185 0.179 DBMET01094 0.241 0.132 DBMET01095 0.259 0.119 DBMET01096 0.319 0.08 DBMET01097 0.249 0.126 DBMET01098 | DBMET01093 | |
| 0.289 | 0.097 | 0.296 | Vasodilator, coronary | 0.272 0.112 DBMET00282 0.296 0.091 DBMET01092 0.206 0.176 DBMET01093 0.198 0.184 DBMET01094 0.229 0.155 DBMET01095 0.193 0.189 DBMET01096 0.269 0.116 DBMET01097 0.198 0.184 DBMET01098 | DBMET01092 | |
| 0.303 | 0.112 | 0.341 | Calpain 2 inhibitor | 0.243 0.154 DBMET01092 0.297 0.116 DBMET01094 0.341 0.091 DBMET01095 | DBMET01095 | |
| 0.191 | 0.005 | 0.191 | Acetylcholine M3 receptor agonist | 0.161 0.014 DBMET01092 0.174 0.009 DBMET01093 | ||
| 0.215 | 0.03 | 0.552 | Alpha-N-acetylglucosaminidase inhibitor | 0.299 0.016 DBMET00282 0.19 0.037 DBMET01092 0.285 0.018 DBMET01093 0.393 0.009 DBMET01094 0.552 0.004 DBMET01095 0.172 0.044 DBMET01096 0.372 0.01 DBMET01097 0.212 0.031 DBMET01098 | DBMET01095 | |
| 0.212 | 0.03 | 0.212 | Nav1.2 sodium channel blocker | 0.112 0.093 DBMET00282 0.164 0.05 DBMET01092 0.177 0.044 DBMET01093 | ||
| 0.186 | 0.013 | 0.37 | Triose-phosphate isomerase inhibitor | 0.163 0.017 DBMET00282 0.174 0.014 DBMET01092 0.239 0.007 DBMET01093 0.214 0.009 DBMET01094 0.37 0.004 DBMET01095 0.091 0.058 DBMET01096 0.204 0.01 DBMET01097 0.103 0.044 DBMET01098 | DBMET01095 | |
| 0.337 | 0.166 | 0.437 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.296 0.219 DBMET01093 0.437 0.07 DBMET01095 0.375 0.124 DBMET01096 0.358 0.142 DBMET01098 | DBMET01095 | |
| 0.198 | 0.027 | 0.218 | Alkylator | 0.218 0.022 DBMET01092 0.177 0.034 DBMET01093 0.153 0.045 DBMET01096 0.109 0.079 DBMET01097 | DBMET01092 | |
| 0.256 | 0.086 | 0.372 | 5 Hydroxytryptamine release stimulant | 0.258 0.085 DBMET01092 0.205 0.117 DBMET01093 0.372 0.052 DBMET01095 0.207 0.115 DBMET01096 0.192 0.128 DBMET01098 | DBMET01095 | |
| 0.188 | 0.023 | 0.2 | Microtubule formation inhibitor | 0.101 0.09 DBMET00282 0.186 0.023 DBMET01092 0.188 0.023 DBMET01093 0.102 0.087 DBMET01094 0.134 0.048 DBMET01095 0.2 0.02 DBMET01096 0.102 0.087 DBMET01097 0.153 0.036 DBMET01098 | DBMET01096 | |
| 0.197 | 0.031 | 0.269 | Cell wall synthesis inhibitor | 0.215 0.025 DBMET01092 0.269 0.013 DBMET01093 0.113 0.111 DBMET01095 0.132 0.084 DBMET01096 0.153 0.062 DBMET01097 | DBMET01093 | |
| 0.193 | 0.032 | 0.193 | Sodium channel (voltage-gated) blocker | 0.134 0.069 DBMET00282 0.127 0.077 DBMET01092 | ||
| 0.205 | 0.045 | 0.439 | Succinate dehydrogenase inhibitor | 0.21 0.042 DBMET00282 0.219 0.036 DBMET01092 0.227 0.032 DBMET01093 0.245 0.024 DBMET01094 0.439 0.004 DBMET01095 0.177 0.071 DBMET01096 0.242 0.025 DBMET01097 0.219 0.036 DBMET01098 | DBMET01095 | |
| 0.181 | 0.024 | 0.211 | GABA C receptor agonist | 0.125 0.046 DBMET00282 0.173 0.026 DBMET01092 0.211 0.019 DBMET01093 0.101 0.065 DBMET01094 0.198 0.021 DBMET01095 0.122 0.048 DBMET01096 0.21 0.019 DBMET01097 0.184 0.024 DBMET01098 | DBMET01093 | |
| 0.195 | 0.039 | 0.321 | Insulin secretagoues | 0.206 0.033 DBMET00282 0.197 0.037 DBMET01092 0.125 0.104 DBMET01094 0.321 0.01 DBMET01097 | DBMET01097 | |
| 0.191 | 0.036 | 0.191 | Sodium channel blocker | 0.151 0.058 DBMET00282 0.122 0.081 DBMET01092 | ||
| 0.168 | 0.013 | 0.168 | GABA A receptor agonist | 0.113 0.028 DBMET01092 0.097 0.04 DBMET01093 | ||
| 0.198 | 0.045 | 0.246 | Phospholipase C inhibitor | 0.212 0.037 DBMET00282 0.246 0.026 DBMET01092 0.171 0.071 DBMET01093 0.172 0.07 DBMET01094 0.161 0.086 DBMET01095 0.142 0.123 DBMET01096 0.224 0.032 DBMET01097 0.137 0.135 DBMET01098 | DBMET01092 | |
| 0.278 | 0.129 | 0.445 | Immunosuppressant | 0.309 0.11 DBMET01092 0.445 0.048 DBMET01098 | DBMET01098 | |
| 0.173 | 0.026 | 0.9 | Nav1.4 sodium channel blocker | 0.178 0.024 DBMET01092 0.142 0.037 DBMET01093 0.9 0 DBMET01096 0.107 0.066 DBMET01097 | DBMET01096 | |
| 0.176 | 0.031 | 0.176 | Nav1.6 sodium channel blocker | 0.147 0.057 DBMET01092 0.176 0.031 DBMET01093 0.147 0.057 DBMET01096 | ||
| 0.172 | 0.033 | 0.173 | Cathepsin H inhibitor | 0.133 0.061 DBMET00282 0.138 0.056 DBMET01092 0.149 0.047 DBMET01093 0.173 0.032 DBMET01094 0.168 0.035 DBMET01095 0.142 0.052 DBMET01097 0.103 0.102 DBMET01098 | DBMET01094 | |
| 0.143 | 0.005 | 0.143 | Acetylcholine M5 receptor agonist | 0.067 0.047 DBMET00282 0.1 0.02 DBMET01092 0.096 0.022 DBMET01093 | ||
| 0.145 | 0.009 | 0.178 | GABA aminotransferase inhibitor | 0.094 0.031 DBMET00282 0.178 0.005 DBMET01092 0.128 0.013 DBMET01093 0.08 0.046 DBMET01094 0.103 0.025 DBMET01095 0.116 0.018 DBMET01097 | DBMET01092 | |
| 0.196 | 0.06 | 0.411 | Peroxidase inhibitor | 0.15 0.078 DBMET00282 0.411 0.019 DBMET01092 0.312 0.035 DBMET01093 0.192 0.061 DBMET01095 0.123 0.097 DBMET01096 0.156 0.075 DBMET01097 0.139 0.084 DBMET01098 | DBMET01092 | |
| 0.147 | 0.012 | 0.215 | Carbamoyl phosphate synthetase inhibitor | 0.089 0.024 DBMET00282 0.139 0.013 DBMET01092 0.215 0.007 DBMET01093 0.058 0.045 DBMET01094 0.071 0.034 DBMET01095 0.079 0.029 DBMET01096 0.11 0.018 DBMET01097 0.07 0.035 DBMET01098 | DBMET01093 | |
| 0.223 | 0.092 | 0.241 | Calpain inhibitor | 0.188 0.126 DBMET01092 0.211 0.103 DBMET01094 0.241 0.073 DBMET01095 | DBMET01095 | |
| 0.23 | 0.101 | 0.333 | Transcription factor STAT3 inhibitor | 0.254 0.08 DBMET01092 0.229 0.102 DBMET01093 0.333 0.039 DBMET01095 | DBMET01095 | |
| 0.181 | 0.053 | 0.211 | Arachidonic acid antagonist | 0.189 0.044 DBMET00282 0.194 0.039 DBMET01092 0.175 0.059 DBMET01093 0.156 0.081 DBMET01094 0.182 0.052 DBMET01095 0.167 0.069 DBMET01096 0.211 0.023 DBMET01097 0.172 0.063 DBMET01098 | DBMET01097 | |
| 0.167 | 0.039 | 0.188 | Adenylate cyclase stimulant | 0.146 0.07 DBMET00282 0.188 0.02 DBMET01092 0.18 0.026 DBMET01093 0.163 0.044 DBMET01095 0.163 0.044 DBMET01096 0.151 0.062 DBMET01097 0.157 0.052 DBMET01098 | DBMET01092 | |
| 0.138 | 0.011 | 0.138 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 DBMET00282 0.133 0.013 DBMET01092 0.091 0.054 DBMET01093 0.083 0.072 DBMET01094 0.103 0.036 DBMET01097 | ||
| 0.251 | 0.125 | 0.416 | Antithrombotic | 0.337 0.069 DBMET00282 0.273 0.108 DBMET01092 0.288 0.096 DBMET01093 0.325 0.074 DBMET01094 0.224 0.15 DBMET01095 0.416 0.045 DBMET01097 | DBMET01097 | |
| 0.155 | 0.031 | 0.991 | Nav1.1 sodium channel blocker | 0.121 0.048 DBMET00282 0.146 0.035 DBMET01092 0.278 0.01 DBMET01093 0.116 0.051 DBMET01094 0.991 0 DBMET01096 0.094 0.074 DBMET01097 | DBMET01096 | |
| 0.146 | 0.024 | 0.146 | Calcium antagonist | 0.074 0.069 DBMET01092 0.101 0.047 DBMET01093 | ||
| 0.127 | 0.009 | 0.127 | Protease 3C (Human rhinovirus) inhibitor | 0.104 0.014 DBMET01092 0.105 0.014 DBMET01093 0.064 0.044 DBMET01094 0.083 0.025 DBMET01095 0.062 0.049 DBMET01096 | ||
| 0.152 | 0.037 | 0.171 | Vanilloid 1 agonist | 0.135 0.057 DBMET00282 0.171 0.023 DBMET01092 0.126 0.074 DBMET01093 0.113 0.107 DBMET01094 0.139 0.051 DBMET01095 0.141 0.048 DBMET01097 | DBMET01092 | |
| 0.131 | 0.019 | 0.139 | Ornithine decarboxylase inhibitor | 0.095 0.05 DBMET00282 0.139 0.015 DBMET01092 0.117 0.028 DBMET01093 0.11 0.034 DBMET01094 0.122 0.024 DBMET01095 0.117 0.028 DBMET01097 | DBMET01092 | |
| 0.139 | 0.027 | 0.171 | Prolactin inhibitor | 0.093 0.063 DBMET00282 0.171 0.015 DBMET01092 0.089 0.068 DBMET01093 0.09 0.066 DBMET01094 0.134 0.03 DBMET01095 0.104 0.051 DBMET01096 0.1 0.055 DBMET01097 0.11 0.046 DBMET01098 | DBMET01092 | |
| 0.151 | 0.041 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.154 0.033 DBMET00282 0.15 0.043 DBMET01092 0.157 0.028 DBMET01093 0.14 0.075 DBMET01094 0.158 0.027 DBMET01095 0.154 0.033 DBMET01096 0.153 0.035 DBMET01097 0.156 0.031 DBMET01098 | DBMET01095 | |
| 0.153 | 0.044 | 0.153 | Antibacterial (Helicobacter pylori) | 0.148 0.048 DBMET01092 | ||
| 0.143 | 0.034 | 0.197 | GABA C receptor antagonist | 0.094 0.088 DBMET00282 0.139 0.037 DBMET01092 0.163 0.024 DBMET01093 0.197 0.013 DBMET01095 0.137 0.038 DBMET01096 0.136 0.039 DBMET01097 0.151 0.029 DBMET01098 | DBMET01095 | |
| 0.199 | 0.09 | 0.227 | Nitric-oxide synthase stimulant | 0.219 0.061 DBMET01092 0.198 0.091 DBMET01093 0.199 0.091 DBMET01095 0.206 0.08 DBMET01096 0.227 0.052 DBMET01098 | DBMET01098 | |
| 0.22 | 0.113 | 0.316 | Transcription factor STAT inhibitor | 0.252 0.085 DBMET01092 0.205 0.132 DBMET01093 0.316 0.047 DBMET01095 | DBMET01095 | |
| 0.152 | 0.047 | 0.152 | Nav1.3 sodium channel blocker | 0.106 0.09 DBMET01092 0.146 0.05 DBMET01093 | ||
| 0.133 | 0.03 | 0.215 | NMDA receptor antagonist | 0.117 0.037 DBMET00282 0.215 0.012 DBMET01092 0.078 0.068 DBMET01096 0.079 0.067 DBMET01097 0.078 0.068 DBMET01098 | DBMET01092 | |
| 0.109 | 0.006 | 0.144 | Exportin-1 inhibitor | 0.08 0.025 DBMET01092 0.092 0.013 DBMET01093 0.144 0.004 DBMET01095 | DBMET01095 | |
| 0.134 | 0.032 | 0.216 | HIV-1 integrase (Overall Integration) inhibitor | 0.181 0.016 DBMET00282 0.146 0.027 DBMET01092 0.108 0.048 DBMET01093 0.113 0.044 DBMET01094 0.097 0.058 DBMET01095 0.104 0.051 DBMET01096 0.216 0.009 DBMET01097 0.148 0.026 DBMET01098 | DBMET01097 | |
| 0.123 | 0.028 | 0.123 | Glutamate (mGluR7) agonist | 0.09 0.083 DBMET01097 | ||
| 0.117 | 0.024 | 0.117 | Glutamate release inhibitor | 0.098 0.045 DBMET00282 0.11 0.03 DBMET01092 0.094 0.052 DBMET01093 0.085 0.074 DBMET01094 0.111 0.029 DBMET01097 | ||
| 0.26 | 0.168 | 0.348 | Antibacterial | 0.329 0.115 DBMET01092 0.348 0.103 DBMET01093 0.275 0.154 DBMET01095 0.261 0.167 DBMET01097 0.243 0.184 DBMET01098 | DBMET01093 | |
| 0.165 | 0.075 | 0.195 | Catenin beta inhibitor | 0.195 0.036 DBMET01092 0.169 0.067 DBMET01093 | DBMET01092 | |
| 0.103 | 0.014 | 0.131 | GABA B receptor agonist | 0.094 0.021 DBMET00282 0.129 0.005 DBMET01092 0.084 0.034 DBMET01093 0.076 0.05 DBMET01094 0.131 0.005 DBMET01097 | DBMET01097 | |
| 0.196 | 0.107 | 0.471 | Aldehyde oxidase inhibitor | 0.471 0.037 DBMET00282 0.404 0.046 DBMET01092 0.295 0.068 DBMET01093 0.287 0.07 DBMET01094 0.441 0.041 DBMET01095 0.161 0.129 DBMET01096 0.439 0.041 DBMET01097 0.177 0.118 DBMET01098 | DBMET00282 | |
| 0.133 | 0.045 | 0.354 | TRPA1 agonist | 0.148 0.032 DBMET01092 0.126 0.052 DBMET01094 0.354 0.004 DBMET01095 0.097 0.094 DBMET01097 | DBMET01095 | |
| 0.126 | 0.039 | 0.286 | Adenylate kinase inhibitor | 0.1 0.067 DBMET00282 0.115 0.048 DBMET01092 0.144 0.029 DBMET01093 0.138 0.032 DBMET01094 0.286 0.008 DBMET01095 0.138 0.032 DBMET01096 0.134 0.034 DBMET01097 0.123 0.041 DBMET01098 | DBMET01095 | |
| 0.122 | 0.039 | 0.133 | Sphingomyelinase inhibitor | 0.087 0.076 DBMET00282 0.103 0.056 DBMET01092 0.133 0.033 DBMET01093 | DBMET01093 | |
| 0.12 | 0.039 | 0.277 | Factor V inhibitor | 0.115 0.045 DBMET00282 0.105 0.059 DBMET01092 0.129 0.031 DBMET01093 0.235 0.003 DBMET01094 0.277 0.002 DBMET01095 0.121 0.038 DBMET01097 | DBMET01095 | |
| 0.116 | 0.035 | 0.144 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.041 DBMET01092 0.144 0.014 DBMET01093 0.111 0.041 DBMET01095 0.085 0.082 DBMET01098 | DBMET01093 | |
| 0.089 | 0.008 | 0.089 | Kainate receptor antagonist | 0.077 0.01 DBMET01092 | ||
| 0.166 | 0.085 | 0.312 | Amyloid beta precursor protein antagonist | 0.197 0.059 DBMET01092 0.163 0.088 DBMET01094 0.312 0.014 DBMET01097 | DBMET01097 | |
| 0.09 | 0.009 | 0.09 | Acetylcholine M2 receptor agonist | 0.067 0.022 DBMET01092 0.072 0.018 DBMET01093 | ||
| 0.113 | 0.033 | 0.113 | Acetylcholine nicotinic antagonist | 0.086 0.049 DBMET01092 0.077 0.058 DBMET01095 | ||
| 0.162 | 0.083 | 0.279 | 3C-like protease (Human coronavirus) inhibitor | 0.279 0.017 DBMET01095 | DBMET01095 | |
| 0.239 | 0.164 | 0.321 | Histamine release inhibitor | 0.225 0.176 DBMET00282 0.321 0.113 DBMET01092 0.216 0.185 DBMET01095 0.273 0.139 DBMET01097 0.274 0.139 DBMET01098 | DBMET01092 | |
| 0.09 | 0.015 | 0.113 | Glutamate (mGluR6) antagonist | 0.072 0.035 DBMET00282 0.079 0.025 DBMET01092 0.101 0.01 DBMET01093 0.064 0.053 DBMET01094 0.075 0.03 DBMET01095 0.083 0.021 DBMET01096 0.094 0.013 DBMET01097 0.113 0.007 DBMET01098 | DBMET01098 | |
| 0.11 | 0.036 | 0.186 | Catalase inhibitor | 0.067 0.058 DBMET00282 0.103 0.038 DBMET01092 0.186 0.018 DBMET01093 0.1 0.038 DBMET01094 0.115 0.034 DBMET01095 0.103 0.037 DBMET01097 | DBMET01093 | |
| 0.099 | 0.025 | 0.13 | Estrogen-related receptor beta agonist | 0.107 0.017 DBMET00282 0.13 0.007 DBMET01092 0.083 0.059 DBMET01093 0.087 0.047 DBMET01094 0.096 0.03 DBMET01095 0.08 0.066 DBMET01096 0.102 0.022 DBMET01097 0.085 0.051 DBMET01098 | DBMET01092 | |
| 0.213 | 0.139 | 0.263 | Insulysin inhibitor | 0.211 0.14 DBMET00282 0.229 0.118 DBMET01092 0.186 0.179 DBMET01094 0.232 0.114 DBMET01095 0.263 0.085 DBMET01097 0.197 0.162 DBMET01098 | DBMET01097 | |
| 0.123 | 0.052 | 0.303 | Ferrochelatase inhibitor | 0.159 0.034 DBMET01093 0.303 0.007 DBMET01095 0.136 0.044 DBMET01097 | DBMET01095 | |
| 0.207 | 0.138 | 0.285 | Gastrin inhibitor | 0.21 0.134 DBMET00282 0.285 0.044 DBMET01097 0.193 0.16 DBMET01098 | DBMET01097 | |
| 0.166 | 0.098 | 0.446 | Non-steroidal antiinflammatory agent | 0.188 0.081 DBMET00282 0.18 0.087 DBMET01092 0.22 0.057 DBMET01094 0.313 0.025 DBMET01095 0.446 0.009 DBMET01097 | DBMET01097 | |
| 0.084 | 0.02 | 0.103 | Ornithine carbamoyltransferase inhibitor | 0.072 0.025 DBMET00282 0.069 0.026 DBMET01092 0.1 0.016 DBMET01093 0.089 0.019 DBMET01094 0.103 0.015 DBMET01095 0.091 0.018 DBMET01097 | DBMET01095 | |
| 0.117 | 0.054 | 0.117 | Acetylcholine release stimulant | 0.101 0.086 DBMET01095 | ||
| 0.112 | 0.049 | 0.291 | UDP-glucose 4-epimerase inhibitor | 0.13 0.037 DBMET00282 0.123 0.042 DBMET01092 0.132 0.036 DBMET01093 0.174 0.022 DBMET01094 0.291 0.011 DBMET01095 0.119 0.044 DBMET01096 0.109 0.052 DBMET01097 0.111 0.05 DBMET01098 | DBMET01095 | |
| 0.095 | 0.034 | 0.212 | Phosphofructokinase-1 inhibitor | 0.092 0.035 DBMET00282 0.107 0.029 DBMET01092 0.138 0.021 DBMET01093 0.12 0.025 DBMET01094 0.212 0.01 DBMET01095 0.088 0.037 DBMET01096 0.122 0.024 DBMET01097 0.072 0.046 DBMET01098 | DBMET01095 | |
| 0.076 | 0.015 | 0.099 | Aconitate hydratase inhibitor | 0.062 0.024 DBMET00282 0.06 0.026 DBMET01092 0.099 0.009 DBMET01093 0.053 0.034 DBMET01094 0.08 0.014 DBMET01095 0.052 0.036 DBMET01096 0.099 0.009 DBMET01097 0.056 0.031 DBMET01098 | DBMET01097 | |
| 0.093 | 0.032 | 0.093 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.097 | 0.039 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | 0.094 0.043 DBMET01092 0.092 0.047 DBMET01093 0.105 0.029 DBMET01095 0.08 0.074 DBMET01096 0.085 0.063 DBMET01097 0.086 0.059 DBMET01098 | DBMET01095 | |
| 0.168 | 0.11 | 0.211 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.211 0.063 DBMET01092 0.158 0.132 DBMET01093 0.168 0.111 DBMET01096 0.176 0.099 DBMET01098 | DBMET01092 | |
| 0.08 | 0.024 | 0.255 | Alcohol oxidase inhibitor | 0.067 0.031 DBMET00282 0.168 0.009 DBMET01092 0.128 0.013 DBMET01093 0.112 0.016 DBMET01094 0.255 0.005 DBMET01095 0.091 0.021 DBMET01097 0.05 0.045 DBMET01098 | DBMET01095 | |
| 0.105 | 0.05 | 0.166 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.062 DBMET00282 0.09 0.065 DBMET01092 0.111 0.045 DBMET01093 0.166 0.022 DBMET01095 0.101 0.053 DBMET01096 0.123 0.037 DBMET01097 0.095 0.059 DBMET01098 | DBMET01095 | |
| 0.166 | 0.112 | 0.221 | Insulin sensitizer | 0.176 0.099 DBMET00282 0.188 0.086 DBMET01092 0.166 0.113 DBMET01093 0.166 0.112 DBMET01095 0.221 0.054 DBMET01097 | DBMET01097 | |
| 0.122 | 0.069 | 0.234 | Aldehyde dehydrogenase inhibitor | 0.127 0.064 DBMET00282 0.174 0.036 DBMET01092 0.118 0.073 DBMET01093 0.191 0.03 DBMET01094 0.234 0.021 DBMET01095 0.136 0.057 DBMET01097 | DBMET01095 | |
| 0.217 | 0.165 | 0.337 | Sodium/bile acid cotransporter inhibitor | 0.276 0.102 DBMET00282 0.328 0.055 DBMET01092 0.337 0.048 DBMET01097 0.205 0.181 DBMET01098 | DBMET01097 | |
| 0.136 | 0.085 | 0.153 | Thiol protease inhibitor | 0.15 0.069 DBMET01094 0.153 0.066 DBMET01095 | DBMET01095 | |
| 0.084 | 0.034 | 0.095 | Glycine receptor agonist | 0.071 0.054 DBMET00282 0.084 0.034 DBMET01092 0.08 0.039 DBMET01093 0.08 0.039 DBMET01095 0.073 0.048 DBMET01096 0.08 0.039 DBMET01097 0.095 0.024 DBMET01098 | DBMET01098 | |
| 0.109 | 0.059 | 0.162 | Aminopeptidase B inhibitor | 0.132 0.046 DBMET00282 0.108 0.059 DBMET01092 0.116 0.055 DBMET01093 0.144 0.04 DBMET01094 0.15 0.038 DBMET01095 0.162 0.033 DBMET01097 | DBMET01097 | |
| 0.086 | 0.037 | 0.092 | Aminopeptidase I inhibitor | 0.078 0.044 DBMET00282 0.081 0.041 DBMET01092 0.09 0.034 DBMET01093 0.079 0.043 DBMET01095 0.092 0.033 DBMET01097 | DBMET01097 | |
| 0.051 | 0.003 | 0.051 | Vasopressin 1A agonist | 0.031 0.015 DBMET00282 0.045 0.004 DBMET01092 0.033 0.012 DBMET01093 0.028 0.021 DBMET01094 0.028 0.02 DBMET01097 | ||
| 0.111 | 0.064 | 0.162 | Mucolytic | 0.136 0.041 DBMET00282 0.136 0.042 DBMET01092 0.13 0.046 DBMET01093 0.101 0.076 DBMET01094 0.114 0.06 DBMET01095 0.162 0.026 DBMET01097 | DBMET01097 | |
| 0.075 | 0.029 | 0.144 | Biliverdin reductase inhibitor | 0.057 0.043 DBMET01092 0.101 0.018 DBMET01093 0.144 0.01 DBMET01095 0.052 0.05 DBMET01096 0.086 0.023 DBMET01097 | DBMET01095 | |
| 0.095 | 0.05 | 0.113 | NADH dehydrogenase inhibitor | 0.1 0.044 DBMET00282 0.103 0.041 DBMET01092 0.11 0.034 DBMET01093 0.112 0.034 DBMET01095 0.113 0.033 DBMET01096 0.106 0.038 DBMET01097 0.101 0.043 DBMET01098 | DBMET01096 | |
| 0.09 | 0.047 | 0.09 | Histamine H2 receptor antagonist | |||
| 0.134 | 0.092 | 0.206 | Heat shock protein 90 antagonist | 0.206 0.035 DBMET01092 | DBMET01092 | |
| 0.069 | 0.027 | 0.094 | Acyl-CoA dehydrogenase inhibitor | 0.053 0.04 DBMET01092 0.081 0.022 DBMET01093 0.094 0.018 DBMET01095 0.051 0.042 DBMET01096 0.065 0.03 DBMET01097 | DBMET01095 | |
| 0.057 | 0.016 | 0.057 | Histamine H2 receptor agonist | 0.038 0.037 DBMET00282 | ||
| 0.103 | 0.063 | 0.103 | Protease inhibitor | 0.089 0.076 DBMET01092 0.091 0.074 DBMET01093 0.099 0.067 DBMET01094 | ||
| 0.113 | 0.073 | 0.137 | Adenylate cyclase inhibitor | 0.137 0.054 DBMET01092 | DBMET01092 | |
| 0.044 | 0.005 | 0.044 | Glutamate (mGluR1a) agonist | 0.029 0.009 DBMET01092 0.034 0.007 DBMET01093 0.025 0.012 DBMET01097 0.02 0.018 DBMET01098 | ||
| 0.1 | 0.062 | 0.151 | GABA C receptor rho-1 antagonist | 0.09 0.078 DBMET01092 0.108 0.052 DBMET01093 0.151 0.021 DBMET01095 0.094 0.071 DBMET01096 | DBMET01095 | |
| 0.068 | 0.03 | 0.104 | Heat shock protein 90 beta antagonist | 0.104 0.01 DBMET01092 | DBMET01092 | |
| 0.081 | 0.044 | 0.125 | Glutamate dehydrogenase inhibitor | 0.08 0.045 DBMET01092 0.11 0.026 DBMET01093 0.125 0.021 DBMET01095 0.067 0.061 DBMET01096 0.093 0.034 DBMET01097 | DBMET01095 | |
| 0.099 | 0.063 | 0.159 | Carbonic anhydrase III inhibitor | 0.159 0.025 DBMET01092 0.136 0.034 DBMET01093 | DBMET01092 | |
| 0.173 | 0.137 | 0.314 | Immunostimulant | 0.25 0.096 DBMET00282 0.219 0.109 DBMET01092 0.268 0.089 DBMET01094 0.216 0.111 DBMET01095 0.314 0.075 DBMET01097 | DBMET01097 | |
| 0.1 | 0.064 | 0.137 | Folate antagonist | 0.106 0.055 DBMET00282 0.093 0.079 DBMET01092 0.137 0.028 DBMET01097 | DBMET01097 | |
| 0.098 | 0.062 | 0.169 | Creatine kinase inhibitor | 0.096 0.064 DBMET00282 0.169 0.017 DBMET01092 0.12 0.041 DBMET01093 0.112 0.047 DBMET01095 0.093 0.067 DBMET01096 0.089 0.073 DBMET01097 0.1 0.059 DBMET01098 | DBMET01092 | |
| 0.095 | 0.061 | 0.113 | Bile acid receptor antagonist | 0.089 0.075 DBMET00282 0.108 0.034 DBMET01092 0.113 0.027 DBMET01097 0.097 0.056 DBMET01098 | DBMET01097 | |
| 0.039 | 0.005 | 0.039 | Glutamate (mGluR1) agonist | 0.031 0.009 DBMET01092 0.035 0.007 DBMET01093 0.028 0.011 DBMET01095 0.026 0.015 DBMET01097 | ||
| 0.079 | 0.045 | 0.206 | Glutamate decarboxylase inhibitor | 0.095 0.033 DBMET00282 0.116 0.022 DBMET01092 0.102 0.028 DBMET01093 0.122 0.02 DBMET01094 0.206 0.006 DBMET01095 0.127 0.019 DBMET01097 | DBMET01095 | |
| 0.061 | 0.028 | 0.12 | Urokinase inhibitor | 0.12 0.012 DBMET00282 0.047 0.034 DBMET01092 0.08 0.021 DBMET01094 0.041 0.038 DBMET01096 0.095 0.018 DBMET01097 | DBMET00282 | |
| 0.103 | 0.07 | 0.148 | DOPA decarboxylase inhibitor | 0.148 0.023 DBMET01092 0.112 0.055 DBMET01093 0.122 0.043 DBMET01095 0.103 0.069 DBMET01097 0.098 0.08 DBMET01098 | DBMET01092 | |
| 0.093 | 0.062 | 0.093 | Toll-Like receptor 3 antagonist | |||
| 0.132 | 0.101 | 0.216 | GABA C receptor rho-2 antagonist | 0.126 0.114 DBMET01092 0.129 0.108 DBMET01093 0.216 0.022 DBMET01095 0.161 0.06 DBMET01096 0.151 0.073 DBMET01098 | DBMET01095 | |
| 0.074 | 0.044 | 0.074 | Amidase inhibitor | 0.07 0.049 DBMET01092 0.071 0.048 DBMET01095 0.07 0.049 DBMET01098 | ||
| 0.047 | 0.017 | 0.047 | Vascular adhesion protein 1 inhibitor | |||
| 0.122 | 0.092 | 0.151 | Neurotrophic factor | 0.12 0.096 DBMET00282 0.123 0.09 DBMET01092 0.151 0.058 DBMET01094 | DBMET01094 | |
| 0.043 | 0.014 | 0.043 | Acetylcholine M4 receptor agonist | |||
| 0.073 | 0.043 | 0.12 | Phenylalanine 4-hydroxylase inhibitor | 0.067 0.049 DBMET00282 0.116 0.019 DBMET01092 0.12 0.018 DBMET01093 0.112 0.021 DBMET01095 0.081 0.037 DBMET01097 0.08 0.037 DBMET01098 | DBMET01093 | |
| 0.046 | 0.017 | 0.058 | Diamine oxidase inhibitor | 0.034 0.032 DBMET00282 0.047 0.017 DBMET01093 0.058 0.01 DBMET01095 | DBMET01095 | |
| 0.064 | 0.035 | 0.064 | Potassium channel intermediate-conductance Ca-activated blocker | 0.061 0.04 DBMET01098 | ||
| 0.058 | 0.03 | 0.121 | Alpha-mannosidase inhibitor | 0.068 0.018 DBMET00282 0.057 0.03 DBMET01092 0.07 0.017 DBMET01093 0.075 0.014 DBMET01094 0.067 0.019 DBMET01095 0.121 0.005 DBMET01096 0.066 0.02 DBMET01097 0.085 0.009 DBMET01098 | DBMET01096 | |
| 0.105 | 0.079 | 0.138 | Photosensitizer | 0.107 0.075 DBMET01092 0.098 0.094 DBMET01093 0.138 0.039 DBMET01095 0.099 0.091 DBMET01097 | DBMET01095 | |
| 0.035 | 0.009 | 0.035 | Antidiuretic hormone agonist | 0.031 0.013 DBMET01092 | ||
| 0.108 | 0.082 | 0.159 | MAO inhibitor | 0.159 0.056 DBMET01092 0.149 0.061 DBMET01095 | DBMET01092 | |
| 0.059 | 0.033 | 0.077 | Sphingosine kinase 2 inhibitor | 0.077 0.017 DBMET00282 0.067 0.024 DBMET01092 0.053 0.042 DBMET01093 | DBMET00282 | |
| 0.05 | 0.027 | 0.061 | Adenylate cyclase 1 inhibitor | 0.045 0.033 DBMET01092 0.049 0.027 DBMET01093 0.061 0.017 DBMET01095 0.044 0.036 DBMET01096 0.054 0.023 DBMET01098 | DBMET01095 | |
| 0.118 | 0.095 | 0.164 | Protein kinase stimulant | 0.164 0.059 DBMET01092 0.133 0.081 DBMET01095 0.108 0.107 DBMET01097 | DBMET01092 | |
| 0.051 | 0.028 | 0.089 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DBMET00282 0.05 0.029 DBMET01092 0.063 0.016 DBMET01093 0.073 0.011 DBMET01094 0.089 0.006 DBMET01095 0.053 0.026 DBMET01096 0.071 0.012 DBMET01097 0.055 0.023 DBMET01098 | DBMET01095 | |
| 0.029 | 0.006 | 0.029 | Vasopressin 1 agonist | 0.027 0.008 DBMET01092 | ||
| 0.057 | 0.036 | 0.057 | Acetylcholine muscarinic agonist | |||
| 0.154 | 0.132 | 0.217 | Neurotrophic factor enhancer | 0.206 0.071 DBMET01092 0.156 0.129 DBMET01093 0.158 0.127 DBMET01095 0.177 0.102 DBMET01096 0.217 0.061 DBMET01098 | DBMET01098 | |
| 0.108 | 0.087 | 0.149 | Glutamate receptor antagonist | 0.112 0.083 DBMET01092 0.149 0.052 DBMET01096 | DBMET01096 | |
| 0.046 | 0.025 | 0.046 | Glutamate (mGluR4) antagonist | 0.045 0.027 DBMET01097 0.042 0.034 DBMET01098 | ||
| 0.036 | 0.015 | 0.043 | Glutamate (mGluR3) agonist | 0.043 0.008 DBMET01092 0.036 0.015 DBMET01093 0.034 0.018 DBMET01097 | DBMET01092 | |
| 0.064 | 0.043 | 0.071 | Calcium channel P-type blocker | 0.071 0.027 DBMET00282 0.061 0.055 DBMET01095 0.061 0.054 DBMET01097 | DBMET00282 | |
| 0.09 | 0.069 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.056 DBMET00282 0.086 0.076 DBMET01092 | DBMET00282 | |
| 0.058 | 0.037 | 0.175 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.064 0.03 DBMET00282 0.069 0.026 DBMET01093 0.078 0.021 DBMET01094 0.175 0.007 DBMET01095 0.074 0.023 DBMET01096 0.06 0.034 DBMET01097 0.076 0.022 DBMET01098 | DBMET01095 | |
| 0.048 | 0.027 | 0.116 | Mannosidase inhibitor | 0.064 0.015 DBMET00282 0.048 0.028 DBMET01092 0.062 0.015 DBMET01093 0.07 0.011 DBMET01094 0.055 0.02 DBMET01095 0.116 0.005 DBMET01096 0.061 0.016 DBMET01097 0.074 0.01 DBMET01098 | DBMET01096 | |
| 0.075 | 0.055 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.072 0.059 DBMET00282 0.086 0.044 DBMET01092 0.083 0.048 DBMET01093 0.084 0.046 DBMET01094 0.106 0.026 DBMET01095 0.086 0.044 DBMET01096 0.065 0.064 DBMET01097 0.089 0.042 DBMET01098 | DBMET01095 | |
| 0.073 | 0.053 | 0.073 | Acetylcholine M4 receptor antagonist | |||
| 0.05 | 0.03 | 0.05 | Cytokine production stimulant | 0.047 0.039 DBMET01093 | ||
| 0.058 | 0.038 | 0.136 | Argininosuccinate synthase inhibitor | 0.061 0.036 DBMET00282 0.05 0.046 DBMET01092 0.08 0.025 DBMET01093 0.121 0.015 DBMET01094 0.136 0.013 DBMET01095 0.111 0.017 DBMET01097 | DBMET01095 | |
| 0.111 | 0.092 | 0.135 | DNA repair enzyme inhibitor | 0.11 0.096 DBMET01092 0.135 0.048 DBMET01093 | DBMET01093 | |
| 0.025 | 0.006 | 0.025 | Vasopressin 2 agonist | 0.019 0.009 DBMET01092 | ||
| 0.055 | 0.037 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.049 | 0.031 | 0.061 | Potassium channel Kv1.3 blocker | 0.048 0.032 DBMET01092 0.061 0.02 DBMET01095 | DBMET01095 | |
| 0.04 | 0.022 | 0.04 | Bombesin 1 receptor antagonist | |||
| 0.055 | 0.038 | 0.063 | Epithelial sodium channel blocker | 0.063 0.024 DBMET00282 0.052 0.045 DBMET01092 0.05 0.048 DBMET01097 | DBMET00282 | |
| 0.047 | 0.031 | 0.051 | Microtubule stabilization | 0.046 0.034 DBMET01092 0.051 0.027 DBMET01093 | DBMET01093 | |
| 0.044 | 0.029 | 0.044 | Histamine H1 receptor agonist | |||
| 0.039 | 0.024 | 0.043 | Glutamate (mGluR8) agonist | 0.037 0.028 DBMET01092 0.041 0.021 DBMET01093 0.043 0.018 DBMET01095 0.041 0.02 DBMET01097 | DBMET01095 | |
| 0.066 | 0.051 | 0.109 | Glutamate (mGluR7) antagonist | 0.074 0.036 DBMET01095 0.072 0.04 DBMET01096 0.109 0.007 DBMET01098 | DBMET01098 | |
| 0.048 | 0.033 | 0.058 | Cholesterol esterase inhibitor | 0.058 0.02 DBMET01098 | DBMET01098 | |
| 0.03 | 0.016 | 0.064 | Lysine carboxypeptidase inhibitor | 0.037 0.012 DBMET00282 0.03 0.016 DBMET01092 0.025 0.022 DBMET01094 0.064 0.005 DBMET01097 | DBMET01097 | |
| 0.052 | 0.039 | 0.052 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.257 | 0.245 | 0.45 | Caspase 9 stimulant | 0.316 0.177 DBMET01092 0.45 0.083 DBMET01095 0.386 0.12 DBMET01096 0.322 0.171 DBMET01098 | DBMET01095 | |
| 0.099 | 0.087 | 0.099 | Nav1.5 sodium channel blocker | |||
| 0.07 | 0.059 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DBMET01095 | DBMET01095 | |
| 0.023 | 0.013 | 0.03 | Vitamin D receptor antagonist | 0.03 0.007 DBMET00282 0.023 0.013 DBMET01092 0.02 0.019 DBMET01094 0.023 0.014 DBMET01097 | DBMET00282 | |
| 0.074 | 0.064 | 0.095 | MAP kinase kinase 7 inhibitor | 0.095 0.018 DBMET01092 0.079 0.048 DBMET01093 0.076 0.058 DBMET01095 | DBMET01092 | |
| 0.043 | 0.033 | 0.043 | Glutamate (mGluR group III) antagonist | 0.041 0.036 DBMET01097 0.041 0.037 DBMET01098 | ||
| 0.06 | 0.05 | 0.072 | Beta 2 adrenoreceptor agonist | 0.072 0.017 DBMET01092 | DBMET01092 | |
| 0.055 | 0.046 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.047 DBMET01092 | ||
| 0.041 | 0.032 | 0.043 | GABA B receptor antagonist | 0.043 0.029 DBMET01093 | DBMET01093 | |
| 0.032 | 0.023 | 0.032 | Dipeptidyl peptidase II inhibitor | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | 0.026 0.016 DBMET01098 | ||
| 0.082 | 0.073 | 0.119 | MAO B inhibitor | 0.119 0.051 DBMET01092 | DBMET01092 | |
| 0.025 | 0.016 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.036 | 0.027 | 0.036 | Nicotinic receptor beta4 subunit antagonist | 0.034 0.03 DBMET01092 | ||
| 0.093 | 0.085 | 0.176 | Cystathionine beta-synthase inhibitor | 0.093 0.086 DBMET00282 0.176 0.031 DBMET01092 0.102 0.074 DBMET01093 0.107 0.069 DBMET01095 0.107 0.07 DBMET01096 0.141 0.045 DBMET01097 0.122 0.056 DBMET01098 | DBMET01092 | |
| 0.046 | 0.039 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.055 0.022 DBMET01092 0.067 0.009 DBMET01095 | DBMET01095 | |
| 0.037 | 0.032 | 0.064 | Dopamine D5 agonist | 0.064 0.01 DBMET01092 0.039 0.029 DBMET01095 0.055 0.014 DBMET01096 0.05 0.017 DBMET01098 | DBMET01092 | |
| 0.088 | 0.082 | 0.146 | Anabolic | 0.091 0.077 DBMET00282 0.109 0.051 DBMET01092 0.103 0.058 DBMET01093 0.146 0.02 DBMET01095 0.1 0.062 DBMET01096 0.099 0.064 DBMET01097 0.097 0.066 DBMET01098 | DBMET01095 | |
| 0.055 | 0.05 | 0.055 | Acetylcholine M5 receptor antagonist | |||
| 0.025 | 0.019 | 0.033 | Vanilloid 2 agonist | 0.026 0.017 DBMET01092 0.033 0.007 DBMET01095 | DBMET01095 | |
| 0.054 | 0.05 | 0.054 | Acetylcholine M2 receptor antagonist | 0.053 0.051 DBMET01093 | ||
| 0.034 | 0.03 | 0.034 | Glutamate (mGluR3) antagonist | 0.034 0.029 DBMET01097 | ||
| 0.054 | 0.049 | 0.077 | Acetylcholine M3 receptor antagonist | 0.063 0.038 DBMET01092 0.077 0.027 DBMET01093 | DBMET01093 | |
| 0.075 | 0.071 | 0.107 | Glutathione S-transferase inhibitor | 0.078 0.064 DBMET01092 0.107 0.032 DBMET01095 | DBMET01095 | |
| 0.022 | 0.018 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET01092 | ||
| 0.018 | 0.015 | 0.022 | Antibiotic Anthracycline-like | 0.019 0.013 DBMET00282 0.022 0.008 DBMET01092 0.021 0.009 DBMET01093 | DBMET01092 | |
| 0.042 | 0.039 | 0.042 | Antimetabolite | 0.041 0.04 DBMET01094 0.042 0.038 DBMET01097 | ||
| 0.056 | 0.053 | 0.069 | NMDA receptor agonist | 0.069 0.037 DBMET01093 | DBMET01093 | |
| 0.023 | 0.021 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET01093 0.023 0.021 DBMET01097 | DBMET01093 | |
| 0.096 | 0.093 | 0.167 | Proteasome inhibitor | 0.105 0.08 DBMET01094 0.167 0.037 DBMET01095 | DBMET01095 | |
| 0.038 | 0.035 | 0.038 | Acetylcholine M1 receptor agonist | |||
| 0.01 | 0.008 | 0.01 | Angiotensin AT2 receptor agonist | |||
| 0.038 | 0.037 | 0.056 | Kainate receptor agonist | 0.043 0.024 DBMET01093 0.056 0.009 DBMET01095 0.041 0.03 DBMET01097 0.041 0.029 DBMET01098 | DBMET01095 | |
| 0.033 | 0.032 | 0.033 | Tryptase inhibitor | |||
| 0.053 | 0.054 | 0.077 | NMDA receptor glycine site agonist | 0.077 0.03 DBMET01093 | DBMET01093 | |
| 0.085 | 0.087 | 0.126 | Falcipain 3 inhibitor | 0.097 0.073 DBMET01094 0.126 0.05 DBMET01095 | DBMET01095 | |
| 0.044 | 0.047 | 0.049 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.037 DBMET01093 0.047 0.04 DBMET01095 0.046 0.043 DBMET01097 | DBMET01093 | |
| 0.026 | 0.029 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 DBMET00282 0.034 0.009 DBMET01092 0.027 0.024 DBMET01095 | DBMET00282 | |
| 0.037 | 0.041 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.029 DBMET00282 0.045 0.022 DBMET01092 0.044 0.024 DBMET01093 0.044 0.024 DBMET01095 0.042 0.028 DBMET01097 | DBMET01092 | |
| 0.015 | 0.019 | 0.02 | Factor IX inhibitor | 0.019 0.012 DBMET00282 0.02 0.012 DBMET01097 | DBMET01097 | |
| 0.067 | 0.072 | 0.099 | Keratolytic | 0.084 0.043 DBMET00282 0.099 0.031 DBMET01092 0.071 0.063 DBMET01093 0.076 0.055 DBMET01095 0.078 0.052 DBMET01096 0.091 0.037 DBMET01097 0.088 0.039 DBMET01098 | DBMET01092 | |
| 0.069 | 0.074 | 0.104 | Carbonic anhydrase VI inhibitor | 0.104 0.037 DBMET01092 0.086 0.05 DBMET01093 | DBMET01092 | |
| 0.055 | 0.061 | 0.066 | Neuronal nicotinic receptor antagonist | 0.066 0.048 DBMET01095 | DBMET01095 | |
| 0.116 | 0.122 | 0.122 | Hemostatic | 0.122 0.111 DBMET01096 | DBMET01096 | |
| 0.045 | 0.052 | 0.053 | Acetyl-CoA transferase inhibitor | 0.053 0.037 DBMET01093 | DBMET01093 | |
| 0.081 | 0.088 | 0.116 | Urease inhibitor | 0.102 0.064 DBMET01092 0.116 0.049 DBMET01093 | DBMET01093 | |
| 0.12 | 0.126 | 0.13 | Sphingosine 1-phosphate receptor 5 antagonist | 0.13 0.1 DBMET01097 | DBMET01097 | |
| 0.027 | 0.035 | 0.041 | Fumarate hydratase inhibitor | 0.041 0.018 DBMET01093 0.032 0.027 DBMET01095 0.035 0.023 DBMET01097 | DBMET01093 | |
| 0.083 | 0.092 | 0.129 | Expectorant | 0.103 0.066 DBMET00282 0.107 0.061 DBMET01092 0.1 0.068 DBMET01093 0.094 0.076 DBMET01095 0.129 0.045 DBMET01097 | DBMET01097 | |
| 0.044 | 0.054 | 0.196 | Plasminogen activator inhibitor | 0.08 0.025 DBMET00282 0.101 0.015 DBMET01094 0.057 0.042 DBMET01095 0.196 0.004 DBMET01096 0.07 0.032 DBMET01097 | DBMET01096 | |
| 0.028 | 0.037 | 0.038 | Carboxypeptidase B inhibitor | 0.038 0.015 DBMET01097 | DBMET01097 | |
| 0.02 | 0.03 | 0.038 | Uridine phosphorylase inhibitor | 0.038 0.013 DBMET00282 0.024 0.023 DBMET01093 0.028 0.02 DBMET01095 0.027 0.02 DBMET01097 | DBMET00282 | |
| 0.059 | 0.069 | 0.216 | Porphobilinogen synthase inhibitor | 0.082 0.046 DBMET01092 0.084 0.044 DBMET01093 0.216 0.01 DBMET01095 0.074 0.052 DBMET01097 | DBMET01095 | |
| 0.01 | 0.02 | 0.015 | Integrin alphaVbeta6 antagonist | 0.015 0.009 DBMET01097 | DBMET01097 | |
| 0.121 | 0.132 | 0.147 | Interferon gamma antagonist | 0.126 0.121 DBMET00282 0.147 0.082 DBMET01092 0.142 0.089 DBMET01095 0.132 0.106 DBMET01097 | DBMET01092 | |
| 0.153 | 0.165 | 0.227 | Interleukin agonist | 0.195 0.126 DBMET00282 0.227 0.097 DBMET01097 | DBMET01097 | |
| 0.116 | 0.128 | 0.15 | Growth hormone agonist | 0.15 0.087 DBMET01092 0.149 0.088 DBMET01093 0.138 0.098 DBMET01097 | DBMET01092 | |
| 0.035 | 0.048 | 0.045 | Geranyltranstransferase inhibitor | 0.045 0.028 DBMET01095 | DBMET01095 | |
| 0.013 | 0.026 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET01093 | DBMET01093 | |
| 0.017 | 0.031 | 0.02 | Neuraminidase (Influenza B) inhibitor | 0.02 0.017 DBMET00282 | DBMET00282 | |
| 0.015 | 0.03 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.008 DBMET01095 | DBMET01095 | |
| 0.074 | 0.089 | 0.092 | D-Ala-D-Ala ligase inhibitor | 0.092 0.041 DBMET01092 0.078 0.074 DBMET01093 0.082 0.061 DBMET01095 | DBMET01092 | |
| 0.109 | 0.124 | 0.205 | Mannose-6-phosphate isomerase inhibitor | 0.125 0.093 DBMET01094 0.205 0.028 DBMET01095 0.118 0.105 DBMET01098 | DBMET01095 | |
| 0.03 | 0.046 | 0.048 | Substance P antagonist | 0.048 0.018 DBMET01093 | DBMET01093 | |
| 0.073 | 0.09 | 0.084 | mTOR complex 2 inhibitor | 0.084 0.059 DBMET01096 | DBMET01096 | |
| 0.041 | 0.058 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.037 DBMET01095 | DBMET01095 | |
| 0.004 | 0.022 | 0.009 | Integrin alphaVbeta5 antagonist | 0.009 0.007 DBMET01097 | DBMET01097 | |
| 0.04 | 0.058 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.041 DBMET01097 | DBMET01097 | |
| 0.03 | 0.048 | 0.044 | Oxytocin agonist | 0.044 0.028 DBMET01092 | DBMET01092 | |
| 0.078 | 0.096 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 DBMET01094 0.108 0.048 DBMET01095 0.1 0.058 DBMET01097 | DBMET01094 | |
| 0.016 | 0.035 | 0.024 | Retinoid X beta receptor antagonist | 0.024 0.008 DBMET01095 0.021 0.012 DBMET01097 | DBMET01095 | |
| 0.133 | 0.152 | 0.163 | Neurotensin receptor agonist | 0.137 0.136 DBMET00282 0.157 0.085 DBMET01092 0.163 0.073 DBMET01097 | DBMET01097 | |
| 0.082 | 0.101 | 0.105 | Carbonic anhydrase XV inhibitor | 0.105 0.06 DBMET01092 0.09 0.082 DBMET01093 | DBMET01092 | |
| 0.118 | 0.139 | 0.23 | Melanin inhibitor | 0.132 0.111 DBMET00282 0.165 0.064 DBMET01092 0.146 0.088 DBMET01094 0.23 0.032 DBMET01095 0.135 0.105 DBMET01096 0.131 0.113 DBMET01097 0.142 0.093 DBMET01098 | DBMET01095 | |
| 0.019 | 0.041 | 0.03 | Thyroid hormone agonist | 0.03 0.013 DBMET01092 | DBMET01092 | |
| 0.094 | 0.116 | 0.143 | Toll-Like receptor 2 antagonist | 0.143 0.058 DBMET01092 0.122 0.076 DBMET01095 | DBMET01092 | |
| 0.003 | 0.026 | 0.007 | Integrin alpha5beta6 antagonist | 0.007 0.004 DBMET01097 | DBMET01097 | |
| 0.086 | 0.109 | 0.153 | Cholesterol synthesis inhibitor | 0.153 0.043 DBMET00282 0.112 0.073 DBMET01092 0.128 0.058 DBMET01094 0.138 0.051 DBMET01095 0.136 0.053 DBMET01097 | DBMET00282 | |
| 0.014 | 0.038 | 0.03 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.03 0.018 DBMET01095 | DBMET01095 | |
| 0.067 | 0.092 | 0.107 | Potassium channel (Ca-activated) activator | 0.107 0.05 DBMET01092 | DBMET01092 | |
| 0.02 | 0.045 | 0.026 | Complement factor 1s inhibitor | 0.026 0.015 DBMET01095 | DBMET01095 | |
| 0.019 | 0.045 | 0.039 | Arginase inhibitor | 0.039 0.023 DBMET01097 | DBMET01097 | |
| 0.073 | 0.099 | 0.081 | T cell inhibitor | 0.081 0.063 DBMET01097 | DBMET01097 | |
| 0.022 | 0.047 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.037 0.017 DBMET01092 0.04 0.016 DBMET01093 | DBMET01093 | |
| 0.013 | 0.039 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 DBMET01092 | DBMET01092 | |
| 0.028 | 0.055 | 0.067 | GABA uptake inhibitor | 0.036 0.033 DBMET01093 0.067 0.008 DBMET01095 0.038 0.03 DBMET01098 | DBMET01095 | |
| 0.054 | 0.081 | 0.074 | Cathepsin G inhibitor | 0.067 0.058 DBMET01094 0.074 0.049 DBMET01095 0.064 0.063 DBMET01097 | DBMET01095 | |
| 0.05 | 0.078 | 0.099 | Histidine decarboxylase inhibitor | 0.092 0.035 DBMET01092 0.086 0.039 DBMET01093 0.062 0.059 DBMET01095 0.099 0.032 DBMET01097 | DBMET01097 | |
| 0.031 | 0.06 | 0.057 | Glutamate (mGluR group I) agonist | 0.057 0.024 DBMET01098 | DBMET01098 | |
| 0.043 | 0.073 | 0.056 | NMDA 2C receptor antagonist | 0.056 0.052 DBMET01092 0.056 0.05 DBMET01098 | DBMET01098 | |
| 0.098 | 0.128 | 0.132 | Sphingosine 1-phosphate receptor 4 antagonist | 0.132 0.053 DBMET01093 | DBMET01093 | |
| 0.118 | 0.149 | 0.152 | CF transmembrane conductance regulator agonist | 0.146 0.083 DBMET01092 0.152 0.073 DBMET01095 0.135 0.107 DBMET01098 | DBMET01095 | |
| 0.054 | 0.086 | 0.099 | Glutamate receptor agonist | 0.099 0.038 DBMET01098 | DBMET01098 | |
| 0.105 | 0.137 | 0.184 | Phospholipase A2 inhibitor | 0.128 0.103 DBMET01092 0.127 0.105 DBMET01094 0.184 0.052 DBMET01097 | DBMET01097 | |
| 0.068 | 0.1 | 0.166 | Monophenol monooxygenase inhibitor | 0.166 0.041 DBMET01092 | DBMET01092 | |
| 0.01 | 0.043 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.019 0.013 DBMET01095 | DBMET01095 | |
| 0.021 | 0.054 | 0.034 | Retinoid X alpha receptor agonist | 0.034 0.025 DBMET01095 0.034 0.025 DBMET01097 | DBMET01097 | |
| 0.023 | 0.057 | 0.08 | Factor VIIa inhibitor | 0.08 0.014 DBMET00282 0.068 0.015 DBMET01097 | DBMET00282 | |
| 0.024 | 0.059 | 0.036 | Retinoid X alpha receptor antagonist | 0.035 0.022 DBMET01095 0.036 0.02 DBMET01097 | DBMET01097 | |
| 0.021 | 0.056 | 0.037 | Free fatty acid receptor 1 antagonist | 0.037 0.019 DBMET01097 | DBMET01097 | |
| 0.045 | 0.081 | 0.068 | Sphingosine kinase inhibitor | 0.059 0.04 DBMET00282 0.068 0.026 DBMET01095 | DBMET01095 | |
| 0.111 | 0.147 | 0.165 | Heat shock protein 90 alpha antagonist | 0.165 0.073 DBMET01092 | DBMET01092 | |
| 0.037 | 0.073 | 0.071 | Factor IXa inhibitor | 0.071 0.02 DBMET00282 0.063 0.024 DBMET01097 | DBMET00282 | |
| 0.084 | 0.121 | 0.11 | Caspase 3 inhibitor | 0.102 0.088 DBMET01094 0.109 0.077 DBMET01095 0.11 0.075 DBMET01097 | DBMET01097 | |
| 0.027 | 0.064 | 0.041 | Retinoid X receptor antagonist | 0.039 0.025 DBMET01095 0.041 0.022 DBMET01097 | DBMET01097 | |
| 0.029 | 0.067 | 0.149 | Plasmin inhibitor | 0.04 0.039 DBMET00282 0.103 0.017 DBMET01094 0.079 0.022 DBMET01095 0.149 0.011 DBMET01096 | DBMET01096 | |
| 0.06 | 0.098 | 0.102 | Glycine receptor antagonist | 0.073 0.07 DBMET01093 0.102 0.03 DBMET01095 0.08 0.056 DBMET01096 0.095 0.037 DBMET01098 | DBMET01095 | |
| 0.013 | 0.052 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 DBMET01093 | DBMET01093 | |
| 0.036 | 0.075 | 0.056 | Beta 1 adrenoreceptor antagonist | 0.056 0.04 DBMET01092 | DBMET01092 | |
| 0.053 | 0.093 | 0.181 | CYP2A6 inhibitor | 0.181 0.01 DBMET01095 | DBMET01095 | |
| 0.026 | 0.065 | 0.041 | Membrane dipeptidase inhibitor | 0.041 0.025 DBMET01097 | DBMET01097 | |
| 0.026 | 0.069 | 0.068 | Guanylate cyclase inhibitor | 0.038 0.037 DBMET01095 0.068 0.005 DBMET01096 0.052 0.019 DBMET01098 | DBMET01096 | |
| 0.035 | 0.078 | 0.052 | Prolyl endopeptidase inhibitor | 0.052 0.033 DBMET01095 | DBMET01095 | |
| 0.043 | 0.088 | 0.069 | Purinergic P2X1 antagonist | 0.069 0.033 DBMET01095 0.06 0.044 DBMET01096 0.059 0.045 DBMET01098 | DBMET01095 | |
| 0.016 | 0.061 | 0.053 | Retinoid X receptor agonist | 0.053 0.017 DBMET01095 0.032 0.028 DBMET01097 | DBMET01095 | |
| 0.011 | 0.058 | 0.023 | Integrin beta5 antagonist | 0.023 0.012 DBMET01097 | DBMET01097 | |
| 0.012 | 0.059 | 0.033 | Integrin alphaVbeta3 antagonist | 0.033 0.007 DBMET01097 | DBMET01097 | |
| 0.038 | 0.087 | 0.106 | Cathepsin B inhibitor | 0.073 0.027 DBMET01094 0.106 0.014 DBMET01095 | DBMET01095 | |
| 0.016 | 0.066 | 0.041 | Trypsin II inhibitor | 0.03 0.021 DBMET00282 0.041 0.013 DBMET01094 0.028 0.023 DBMET01097 | DBMET01094 | |
| 0.058 | 0.108 | 0.103 | Chymotrypsin inhibitor | 0.073 0.066 DBMET01094 0.093 0.041 DBMET01095 0.103 0.034 DBMET01096 | DBMET01096 | |
| 0.014 | 0.063 | 0.019 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 DBMET01093 | DBMET01093 | |
| 0.162 | 0.212 | 0.452 | Transcription factor NF kappa B inhibitor | 0.199 0.17 DBMET00282 0.258 0.122 DBMET01092 0.452 0.053 DBMET01095 0.286 0.103 DBMET01097 | DBMET01095 | |
| 0.026 | 0.077 | 0.034 | Adenosine uptake inhibitor | 0.034 0.025 DBMET01095 | DBMET01095 | |
| 0.026 | 0.078 | 0.034 | Glutamate (mGluR8) antagonist | 0.034 0.029 DBMET01097 | DBMET01097 | |
| 0.028 | 0.081 | 0.043 | AICAR transformylase inhibitor | 0.04 0.037 DBMET01094 0.043 0.032 DBMET01095 0.04 0.038 DBMET01097 | DBMET01095 | |
| 0.07 | 0.126 | 0.138 | Electrolyte absorption antagonist | 0.138 0.024 DBMET01095 0.115 0.041 DBMET01096 | DBMET01095 | |
| 0.022 | 0.077 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET01096 | DBMET01096 | |
| 0.034 | 0.09 | 0.052 | Leukotriene B4 antagonist | 0.052 0.041 DBMET01097 | DBMET01097 | |
| 0.046 | 0.102 | 0.078 | Caspase 9 inhibitor | 0.07 0.032 DBMET01094 0.078 0.024 DBMET01095 | DBMET01095 | |
| 0.026 | 0.083 | 0.061 | Neuropeptide agonist | 0.061 0.038 DBMET00282 | DBMET00282 | |
| 0.056 | 0.114 | 0.182 | MAO A inhibitor | 0.082 0.078 DBMET01092 0.182 0.033 DBMET01095 | DBMET01095 | |
| 0.039 | 0.098 | 0.065 | Dihydroorotate oxidase inhibitor | 0.065 0.022 DBMET01095 | DBMET01095 | |
| 0.042 | 0.101 | 0.064 | Beta adrenoreceptor antagonist | 0.064 0.048 DBMET01092 | DBMET01092 | |
| 0.109 | 0.169 | 0.139 | Pregnane X receptor agonist | 0.123 0.119 DBMET01093 0.139 0.075 DBMET01095 | DBMET01095 | |
| 0.047 | 0.108 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | 0.081 0.049 DBMET01095 | DBMET01095 | |
| 0.034 | 0.096 | 0.046 | Squalene epoxidase inhibitor | 0.046 0.042 DBMET00282 | DBMET00282 | |
| 0.035 | 0.097 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET01092 | DBMET01092 | |
| 0.084 | 0.147 | 0.113 | Interleukin 8 antagonist | 0.113 0.071 DBMET01097 | DBMET01097 | |
| 0.035 | 0.098 | 0.051 | 5 Hydroxytryptamine 1B agonist | 0.051 0.04 DBMET01096 | DBMET01096 | |
| 0.009 | 0.073 | 0.014 | Integrin beta6 antagonist | 0.014 0.011 DBMET01097 | DBMET01097 | |
| 0.017 | 0.081 | 0.039 | AMPA receptor agonist | 0.039 0.018 DBMET01098 | DBMET01098 | |
| 0.041 | 0.107 | 0.1 | Carbonic anhydrase XIII inhibitor | 0.068 0.06 DBMET01092 0.1 0.038 DBMET01095 | DBMET01095 | |
| 0.013 | 0.079 | 0.025 | Nicotinic acid receptor 2 antagonist | 0.025 0.022 DBMET01095 | DBMET01095 | |
| 0.01 | 0.076 | 0.019 | Integrin alphaVbeta1 antagonist | 0.019 0.013 DBMET01097 | DBMET01097 | |
| 0.008 | 0.075 | 0.036 | Vitronectin receptor antagonist | 0.036 0.009 DBMET01097 | DBMET01097 | |
| 0.014 | 0.082 | 0.128 | Calpain 1 inhibitor | 0.041 0.009 DBMET01094 0.128 0.004 DBMET01095 | DBMET01095 | |
| 0.047 | 0.115 | 0.108 | Trypsin inhibitor | 0.083 0.025 DBMET00282 0.108 0.014 DBMET01094 0.058 0.052 DBMET01095 0.062 0.044 DBMET01096 0.088 0.023 DBMET01097 | DBMET01094 | |
| 0.04 | 0.109 | 0.064 | Kallikrein 1 inhibitor | 0.064 0.029 DBMET01096 0.064 0.029 DBMET01098 | DBMET01098 | |
| 0.01 | 0.082 | 0.081 | Factor VII inhibitor | 0.081 0.008 DBMET01097 | DBMET01097 | |
| 0.046 | 0.118 | 0.081 | Phospholipase D inhibitor | 0.081 0.033 DBMET01095 0.073 0.047 DBMET01098 | DBMET01095 | |
| 0.051 | 0.126 | 0.074 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.043 DBMET01097 | DBMET01097 | |
| 0.142 | 0.218 | 0.214 | Peptidyltransferase inhibitor | 0.214 0.083 DBMET00282 0.2 0.099 DBMET01092 0.204 0.094 DBMET01093 0.198 0.101 DBMET01097 | DBMET00282 | |
| 0.01 | 0.087 | 0.023 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 DBMET01095 | DBMET01095 | |
| 0.02 | 0.098 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET01095 | DBMET01095 | |
| 0.119 | 0.198 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.088 DBMET01095 | DBMET01095 | |
| 0.041 | 0.121 | 0.069 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.069 0.062 DBMET01092 | DBMET01092 | |
| 0.019 | 0.099 | 0.063 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.063 0.021 DBMET01093 | DBMET01093 | |
| 0.064 | 0.148 | 0.216 | Vanilloid agonist | 0.083 0.063 DBMET01092 0.216 0.006 DBMET01095 | DBMET01095 | |
| 0.033 | 0.118 | 0.067 | Leukotriene antagonist | 0.067 0.043 DBMET01097 | DBMET01097 | |
| 0.048 | 0.136 | 0.071 | Interferon agonist | 0.071 0.068 DBMET01095 | DBMET01095 | |
| 0.046 | 0.135 | 0.086 | Macrophage migration inhibitory factor inhibitor | 0.086 0.045 DBMET01092 | DBMET01092 | |
| 0.065 | 0.155 | 0.08 | CC chemokine 5 receptor agonist | 0.08 0.066 DBMET01095 | DBMET01095 | |
| 0.166 | 0.257 | 0.333 | Interleukin 2 agonist | 0.294 0.078 DBMET00282 0.238 0.133 DBMET01092 0.235 0.136 DBMET01094 0.333 0.054 DBMET01097 | DBMET01097 | |
| 0.067 | 0.158 | 0.619 | Cyclooxygenase 1 inhibitor | 0.114 0.087 DBMET01092 0.301 0.014 DBMET01097 0.619 0.004 DBMET01098 | DBMET01098 | |
| 0.032 | 0.124 | 0.041 | Heme oxygenase inhibitor | 0.041 0.035 DBMET01095 | DBMET01095 | |
| 0.108 | 0.201 | 0.207 | Lipocortins synthesis antagonist | 0.136 0.128 DBMET01093 0.19 0.063 DBMET01096 0.166 0.085 DBMET01097 0.207 0.052 DBMET01098 | DBMET01098 | |
| 0.062 | 0.156 | 0.09 | Xanthine oxidase inhibitor | 0.09 0.071 DBMET01092 | DBMET01092 | |
| 0.127 | 0.221 | 0.449 | Hypoglycemic | 0.395 0.028 DBMET00282 0.219 0.097 DBMET01092 0.309 0.05 DBMET01094 0.449 0.021 DBMET01097 | DBMET01097 | |
| 0.041 | 0.136 | 0.054 | Leukotriene C antagonist | 0.054 0.046 DBMET01093 | DBMET01093 | |
| 0.036 | 0.131 | 0.056 | 5 Hydroxytryptamine 3 agonist | 0.056 0.055 DBMET01095 | DBMET01095 | |
| 0.052 | 0.147 | 0.188 | Bronchodilator | 0.092 0.073 DBMET01092 0.188 0.02 DBMET01097 | DBMET01097 | |
| 0.063 | 0.161 | 0.211 | Amylase inhibitor | 0.12 0.081 DBMET01092 0.124 0.079 DBMET01094 0.211 0.041 DBMET01095 | DBMET01095 | |
| 0.009 | 0.109 | 0.138 | GP IIb/IIIa receptor antagonist | 0.057 0.029 DBMET00282 0.138 0.012 DBMET01097 | DBMET01097 | |
| 0.052 | 0.153 | 0.092 | Vanilloid 4 agonist | 0.092 0.023 DBMET01095 | DBMET01095 | |
| 0.044 | 0.149 | 0.076 | Adrenaline agonist | 0.076 0.064 DBMET01092 | DBMET01092 | |
| 0.02 | 0.127 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 DBMET01096 0.045 0.029 DBMET01098 | DBMET01096 | |
| 0.027 | 0.135 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.047 DBMET01095 | DBMET01095 | |
| 0.045 | 0.154 | 0.068 | Transcription factor RelA inhibitor | 0.068 0.033 DBMET01095 | DBMET01095 | |
| 0.161 | 0.271 | 0.217 | MAP kinase kinase 3 inhibitor | 0.217 0.079 DBMET01095 | DBMET01095 | |
| 0.012 | 0.126 | 0.026 | Retinoid X gamma receptor antagonist | 0.026 0.023 DBMET01097 | DBMET01097 | |
| 0.033 | 0.148 | 0.059 | CDC25B inhibitor | 0.059 0.052 DBMET01094 | DBMET01094 | |
| 0.076 | 0.193 | 0.292 | Angiogenesis stimulant | 0.292 0.052 DBMET00282 0.186 0.102 DBMET01092 0.189 0.1 DBMET01097 | DBMET00282 | |
| 0.05 | 0.168 | 0.076 | Estrogen receptor alpha antagonist | 0.076 0.056 DBMET01092 | DBMET01092 | |
| 0.035 | 0.154 | 0.062 | Pregnane X receptor antagonist | 0.053 0.052 DBMET01093 0.062 0.026 DBMET01095 | DBMET01095 | |
| 0.009 | 0.13 | 0.047 | Complement C3a chemotactic receptor antagonist | 0.047 0.028 DBMET01097 | DBMET01097 | |
| 0.009 | 0.13 | 0.051 | Kainate receptor 2 antagonist | 0.051 0.015 DBMET01095 | DBMET01095 | |
| 0.045 | 0.167 | 0.096 | Alcohol dehydrogenase inhibitor | 0.096 0.057 DBMET01095 | DBMET01095 | |
| 0.094 | 0.218 | 0.203 | P-glycoprotein inhibitor | 0.203 0.062 DBMET01096 | DBMET01096 | |
| 0.067 | 0.197 | 0.193 | NADPH oxidase inhibitor | 0.193 0.037 DBMET01095 | DBMET01095 | |
| 0.018 | 0.15 | 0.051 | Glutamate (mGluR5) agonist | 0.051 0.025 DBMET01098 | DBMET01098 | |
| 0.009 | 0.142 | 0.049 | Trypsin I inhibitor | 0.037 0.019 DBMET00282 0.049 0.012 DBMET01094 0.035 0.022 DBMET01096 0.042 0.016 DBMET01097 | DBMET01094 | |
| 0.06 | 0.196 | 0.233 | 3C-Like protease (SARS coronavirus) inhibitor | 0.126 0.017 DBMET01094 0.233 0.004 DBMET01095 | DBMET01095 | |
| 0.015 | 0.152 | 0.053 | Aromatase inhibitor | 0.053 0.046 DBMET01095 | DBMET01095 | |
| 0.012 | 0.15 | 0.035 | NMDA receptor subunit 3A antagonist | 0.035 0.029 DBMET01096 | DBMET01096 | |
| 0.02 | 0.158 | 0.086 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET01094 0.086 0.017 DBMET01095 | DBMET01095 | |
| 0.022 | 0.165 | 0.143 | TRPA1 antagonist | 0.143 0.01 DBMET01095 | DBMET01095 | |
| 0.094 | 0.239 | 0.288 | Free radical scavenger | 0.288 0.055 DBMET01092 | DBMET01092 | |
| 0.024 | 0.172 | 0.059 | Androgen agonist | 0.056 0.046 DBMET01095 0.059 0.043 DBMET01098 | DBMET01098 | |
| 0.031 | 0.179 | 0.064 | Factor III inhibitor | 0.052 0.03 DBMET00282 0.064 0.014 DBMET01095 0.049 0.037 DBMET01097 | DBMET01095 | |
| 0.122 | 0.271 | 0.223 | Hypoxia-inducible factor 1 alpha inhibitor | 0.185 0.171 DBMET01092 0.223 0.126 DBMET01095 | DBMET01095 | |
| 0.002 | 0.154 | 0.013 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.013 0.003 DBMET01094 | DBMET01094 | |
| 0.128 | 0.282 | 0.348 | Vasodilator, peripheral | 0.348 0.075 DBMET01096 | DBMET01096 | |
| 0.004 | 0.158 | 0.021 | 3C-Like protease (MERS coronavirus) inhibitor | 0.014 0.006 DBMET01094 0.021 0.004 DBMET01095 | DBMET01095 | |
| 0.03 | 0.19 | 0.055 | Glucosylceramidase inhibitor | 0.055 0.038 DBMET01096 | DBMET01096 | |
| 0.07 | 0.232 | 0.178 | Pyruvate kinase inhibitor | 0.178 0.094 DBMET01095 | DBMET01095 | |
| 0.031 | 0.194 | 0.113 | Thrombin inhibitor | 0.075 0.048 DBMET00282 0.113 0.02 DBMET01094 | DBMET01094 | |
| 0.065 | 0.234 | 0.317 | Anticoagulant | 0.264 0.035 DBMET00282 0.274 0.033 DBMET01094 0.317 0.026 DBMET01097 | DBMET01097 | |
| 0.087 | 0.261 | 0.208 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.164 0.05 DBMET01096 0.208 0.015 DBMET01098 | DBMET01098 | |
| 0.009 | 0.185 | 0.048 | 1,3-Beta-glucan synthase inhibitor | 0.048 0.003 DBMET01096 | DBMET01096 | |
| 0.026 | 0.203 | 0.055 | Fatty acid synthase inhibitor | 0.055 0.042 DBMET01098 | DBMET01098 | |
| 0.005 | 0.182 | 0.04 | Cholecystokinin A antagonist | 0.04 0.024 DBMET01097 | DBMET01097 | |
| 0.012 | 0.19 | 0.038 | Integrin alpha5beta1 antagonist | 0.038 0.033 DBMET01097 | DBMET01097 | |
| 0.102 | 0.282 | 0.2 | Lipoxygenase inhibitor | 0.184 0.158 DBMET01092 0.195 0.146 DBMET01093 0.2 0.14 DBMET01098 | DBMET01098 | |
| 0.023 | 0.204 | 0.057 | Dopamine D1 antagonist | 0.057 0.054 DBMET01096 | DBMET01096 | |
| 0.022 | 0.209 | 0.363 | DNA gyrase subunit A inhibitor | 0.363 0.002 DBMET01098 | DBMET01098 | |
| 0.118 | 0.308 | 0.258 | Immunomodulator | 0.258 0.109 DBMET01097 | DBMET01097 | |
| 0.045 | 0.237 | 0.111 | Beta glucuronidase inhibitor | 0.111 0.056 DBMET01095 0.099 0.071 DBMET01096 | DBMET01095 | |
| 0.03 | 0.227 | 0.13 | M18 aspartyl aminopeptidase inhibitor | 0.13 0.063 DBMET01092 | DBMET01092 | |
| 0.005 | 0.202 | 0.077 | Leukotriene A4 hydrolase inhibitor | 0.058 0.016 DBMET00282 0.035 0.028 DBMET01094 0.077 0.009 DBMET01097 | DBMET01097 | |
| 0.025 | 0.223 | 0.069 | Elastase 1 inhibitor | 0.069 0.048 DBMET01095 | DBMET01095 | |
| 0.016 | 0.221 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.035 DBMET00282 | DBMET00282 | |
| 0.025 | 0.234 | 0.084 | Topoisomerase II alpha inhibitor | 0.084 0.05 DBMET01098 | DBMET01098 | |
| 0.089 | 0.301 | 0.222 | 5 Hydroxytryptamine 1E antagonist | 0.222 0.106 DBMET01095 | DBMET01095 | |
| 0.065 | 0.284 | 0.2 | Hexokinase inhibitor | 0.139 0.092 DBMET01093 0.2 0.035 DBMET01095 | DBMET01095 | |
| 0.067 | 0.288 | 0.173 | I kappa B kinase epsilon inhibitor | 0.173 0.096 DBMET01095 | DBMET01095 | |
| 0.146 | 0.367 | 0.663 | Apoptosis agonist | 0.281 0.186 DBMET01092 0.286 0.182 DBMET01094 0.613 0.046 DBMET01095 0.663 0.037 DBMET01098 | DBMET01098 | |
| 0.005 | 0.234 | 0.039 | Cholecystokinin antagonist | 0.039 0.03 DBMET01097 | DBMET01097 | |
| 0.016 | 0.245 | 0.064 | Benzodiazepine agonist | 0.064 0.061 DBMET01096 | DBMET01096 | |
| 0.004 | 0.239 | 0.042 | Thyroid hormone alpha antagonist | 0.024 0.006 DBMET00282 0.016 0.01 DBMET01094 0.042 0.004 DBMET01097 | DBMET01097 | |
| 0.069 | 0.305 | 0.252 | Platelet aggregation inhibitor | 0.252 0.05 DBMET01097 | DBMET01097 | |
| 0.032 | 0.27 | 0.076 | Caspase 7 inhibitor | 0.076 0.072 DBMET01095 | DBMET01095 | |
| 0.045 | 0.294 | 0.102 | Toll-Like receptor 4 antagonist | 0.102 0.066 DBMET00282 | DBMET00282 | |
| 0.005 | 0.263 | 0.077 | Integrin antagonist | 0.077 0.02 DBMET01097 | DBMET01097 | |
| 0.044 | 0.303 | 0.085 | Thioredoxin reductase inhibitor | 0.085 0.049 DBMET01095 | DBMET01095 | |
| 0.058 | 0.326 | 0.461 | Nitric oxide antagonist | 0.132 0.116 DBMET01092 0.461 0.019 DBMET01095 | DBMET01095 | |
| 0.033 | 0.305 | 0.098 | Chelator | 0.098 0.081 DBMET01092 | DBMET01092 | |
| 0.034 | 0.308 | 0.097 | Alpha 2c adrenoreceptor antagonist | 0.097 0.068 DBMET01096 | DBMET01096 | |
| 0.054 | 0.331 | 0.151 | Hypolipemic | 0.151 0.135 DBMET00282 | DBMET00282 | |
| 0.021 | 0.297 | 0.054 | CXC chemokine 1 receptor antagonist | 0.054 0.03 DBMET01097 | DBMET01097 | |
| 0.034 | 0.317 | 0.283 | Thrombolytic | 0.283 0.027 DBMET01097 | DBMET01097 | |
| 0.005 | 0.318 | 0.141 | Beta tubulin antagonist | 0.141 0.013 DBMET01095 | DBMET01095 | |
| 0.035 | 0.359 | 0.345 | Cyclooxygenase inhibitor | 0.205 0.04 DBMET01097 0.345 0.011 DBMET01098 | DBMET01098 | |
| 0.029 | 0.376 | 0.093 | Alpha 2b adrenoreceptor antagonist | 0.093 0.081 DBMET01096 | DBMET01096 | |
| 0.008 | 0.366 | 0.092 | Peroxisome proliferator-activated receptor gamma agonist | 0.092 0.032 DBMET01097 | DBMET01097 | |
| 0.005 | 0.37 | 0.047 | Estrogen agonist | 0.047 0.037 DBMET01092 | DBMET01092 | |
| 0.013 | 0.381 | 0.104 | Potassium channel Kv1.5 blocker | 0.104 0.017 DBMET01098 | DBMET01098 | |
| 0.069 | 0.437 | 0.118 | Papain-like protease (SARS coronavirus) inhibitor | 0.118 0.086 DBMET01095 | DBMET01095 | |
| 0.013 | 0.382 | 0.082 | Lipase inhibitor | 0.082 0.041 DBMET01095 | DBMET01095 | |
| 0.039 | 0.417 | 0.327 | Platelet antagonist | 0.209 0.095 DBMET00282 0.327 0.044 DBMET01097 | DBMET01097 | |
| 0.023 | 0.402 | 0.122 | Cell adhesion molecule inhibitor | 0.122 0.023 DBMET01097 | DBMET01097 | |
| 0.05 | 0.438 | 0.212 | Hepatoprotectant | 0.212 0.058 DBMET01095 | DBMET01095 | |
| 0.065 | 0.468 | 0.216 | Transcription factor inhibitor | 0.216 0.212 DBMET01095 | DBMET01095 | |
| 0.032 | 0.451 | 0.169 | Cell adhesion inhibitor | 0.169 0.036 DBMET01097 | DBMET01097 | |
| 0.023 | 0.448 | 0.078 | Factor XII inhibitor | 0.078 0.07 DBMET01094 | DBMET01094 | |
| 0.03 | 0.456 | 0.14 | DNA polymerase I inhibitor | 0.14 0.055 DBMET01097 | DBMET01097 | |
| 0.04 | 0.468 | 0.212 | Antioxidant | 0.212 0.106 DBMET01092 | DBMET01092 | |
| 0.019 | 0.458 | 0.324 | Cyclooxygenase 2 inhibitor | 0.126 0.073 DBMET01097 0.324 0.011 DBMET01098 | DBMET01098 | |
| 0.021 | 0.461 | 0.074 | DNA helicase inhibitor | 0.074 0.014 DBMET01097 | DBMET01097 | |
| 0.015 | 0.461 | 0.145 | Tubulin antagonist | 0.145 0.06 DBMET01095 | DBMET01095 | |
| 0.009 | 0.458 | 0.078 | Estrogen-related receptor beta antagonist | 0.032 0.024 DBMET01092 0.078 0.003 DBMET01095 | DBMET01095 | |
| 0.016 | 0.466 | 0.597 | Topoisomerase II inhibitor | 0.119 0.068 DBMET01096 0.597 0.005 DBMET01098 | DBMET01098 | |
| 0.073 | 0.539 | 0.222 | Apoptosis antagonist | 0.211 0.166 DBMET01094 0.222 0.155 DBMET01095 0.199 0.18 DBMET01097 | DBMET01095 | |
| 0.01 | 0.491 | 0.345 | DNA topoisomerase IV inhibitor | 0.345 0.002 DBMET01098 | DBMET01098 | |
| 0.004 | 0.488 | 0.021 | Retinoic acid receptor agonist | 0.021 0.02 DBMET01095 | DBMET01095 | |
| 0.004 | 0.492 | 0.19 | Dopamine D5 antagonist | 0.19 0.005 DBMET01096 | DBMET01096 | |
| 0.007 | 0.508 | 0.038 | Retinoic acid alpha receptor agonist | 0.038 0.029 DBMET01095 | DBMET01095 | |
| 0.005 | 0.515 | 0.169 | Liver X receptor agonist | 0.169 0.005 DBMET01093 | DBMET01093 | |
| 0.013 | 0.524 | 0.132 | Topoisomerase I inhibitor | 0.132 0.049 DBMET01096 0.101 0.069 DBMET01098 | DBMET01096 | |
| 0.023 | 0.546 | 0.135 | Estrogen antagonist | 0.135 0.033 DBMET01092 0.119 0.057 DBMET01095 | DBMET01092 | |
| 0.014 | 0.546 | 0.123 | Estrogen receptor beta antagonist | 0.123 0.029 DBMET01092 0.096 0.072 DBMET01095 | DBMET01092 | |
| 0.029 | 0.569 | 0.125 | ABCA1 expression enhancer | 0.125 0.027 DBMET01095 | DBMET01095 | |
| 0.005 | 0.572 | 0.063 | Liver X receptor alpha antagonist | 0.063 0.005 DBMET01093 | DBMET01093 | |
| 0.004 | 0.581 | 0.046 | Oxytocin antagonist | 0.046 0.02 DBMET01098 | DBMET01098 | |
| 0.007 | 0.584 | 0.535 | 5-Lipoxygenase inhibitor | 0.125 0.048 DBMET01096 0.535 0.004 DBMET01098 | DBMET01098 | |
| 0.022 | 0.605 | 0.119 | Electron transport complex I inhibitor | 0.119 0.048 DBMET01095 | DBMET01095 | |
| 0.015 | 0.603 | 0.107 | Breast cancer-resistant protein inhibitor | 0.107 0.049 DBMET01095 | DBMET01095 | |
| 0.006 | 0.608 | 0.192 | Alpha tubulin antagonist | 0.192 0.006 DBMET01095 | DBMET01095 | |
| 0.01 | 0.638 | 0.102 | Protein kinase C mu inhibitor | 0.102 0.055 DBMET01096 | DBMET01096 | |
| 0.005 | 0.639 | 0.135 | Liver X receptor antagonist | 0.135 0.004 DBMET01093 | DBMET01093 | |
| 0.004 | 0.66 | 0.319 | Phosphodiesterase 3B inhibitor | 0.319 0.004 DBMET01096 | DBMET01096 | |
| 0.004 | 0.669 | 0.382 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET01094 0.382 0.004 DBMET01095 | DBMET01095 | |
| 0.044 | 0.709 | 0.425 | Antiinflammatory | 0.425 0.124 DBMET01093 0.305 0.211 DBMET01095 0.326 0.192 DBMET01097 | DBMET01093 | |
| 0.028 | 0.694 | 0.379 | Toll-Like receptor 7 agonist | 0.379 0.069 DBMET01093 0.226 0.172 DBMET01097 | DBMET01093 | |
| 0.027 | 0.695 | 0.382 | Toll-Like receptor agonist | 0.382 0.068 DBMET01093 0.225 0.174 DBMET01097 | DBMET01093 | |
| 0.032 | 0.701 | 0.15 | NOS3 expression enhancer | 0.15 0.072 DBMET01098 | DBMET01098 | |
| 0.04 | 0.713 | 0.135 | MAP kinase kinase 4 inhibitor | 0.128 0.119 DBMET01096 0.135 0.099 DBMET01098 | DBMET01098 | |
| 0.009 | 0.683 | 0.117 | Lipid peroxidase inhibitor | 0.117 0.096 DBMET01097 | DBMET01097 | |
| 0.006 | 0.684 | 0.133 | DNA gyrase inhibitor | 0.133 0.01 DBMET01098 | DBMET01098 | |
| 0.033 | 0.712 | 0.408 | Cyclophilin D inhibitor | 0.408 0.086 DBMET01097 | DBMET01097 | |
| 0.008 | 0.71 | 0.117 | Acetyl-CoA transferase 2 inhibitor | 0.117 0.004 DBMET01093 | DBMET01093 | |
| 0.006 | 0.721 | 0.085 | Phosphodiesterase 3A inhibitor | 0.085 0.048 DBMET01098 | DBMET01098 | |
| 0.017 | 0.742 | 0.497 | Angiogenesis inhibitor | 0.497 0.03 DBMET01098 | DBMET01098 | |
| 0.013 | 0.753 | 0.153 | Interleukin 6 antagonist | 0.129 0.126 DBMET01096 0.153 0.085 DBMET01097 | DBMET01097 | |
| 0.005 | 0.785 | 0.234 | Phosphodiesterase III inhibitor | 0.234 0.005 DBMET01096 | DBMET01096 | |
| 0.022 | 0.825 | 0.132 | Ca(v)3.1 blocker | 0.132 0.008 DBMET01095 | DBMET01095 | |
| 0.004 | 0.829 | 0.332 | HIV-1 integrase (3'-Processing) inhibitor | 0.061 0.046 DBMET01094 0.332 0.004 DBMET01095 | DBMET01095 | |
| 0.003 | 0.849 | 0.085 | Phosphodiesterase 10A inhibitor | 0.085 0.013 DBMET01098 | DBMET01098 | |
| 0.003 | 0.849 | 0.085 | Phosphodiesterase X inhibitor | 0.085 0.013 DBMET01098 | DBMET01098 | |
| 0.005 | 0.878 | 0.163 | Phosphodiesterase inhibitor | 0.163 0.05 DBMET01098 | DBMET01098 | |
| 0.013 | 0.919 | 0.265 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.265 0.093 DBMET01096 | DBMET01096 | |
| 0.018 | 0.926 | 0.465 | Caspase 3 stimulant | 0.465 0.026 DBMET01095 0.249 0.113 DBMET01096 | DBMET01095 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |